Last update 01 Nov 2024

SR-1375

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Mechanism-
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesEndocrinology and Metabolic Disease+ [3]
Active Indication
Community Acquired PneumoniaNeuroinflammationDiabetic macular oedema
Inactive Indication-
Originator Organization
Shanghai SIMR Biotech Co., Ltd.Shanghai SIMR Biotech Co., Ltd.
Active Organization
Shanghai SIMRD Biotechnology Co.,LtdShanghai SIMRD Biotechnology Co.,LtdShanghai SIMR Biotech Co., Ltd.Shanghai SIMR Biotech Co., Ltd.SIMR (Australia) Biotech Pty Ltd
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

6
Clinical Trials associated with SR-1375
CTR20242885 / RecruitingPhase 2
一项在成人社区获得性肺炎住院患者中评价SR1375的有效性和安全性的随机、双盲、安慰剂平行对照的Ⅱ期临床研究
[Translation] A randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of SR1375 in adult patients hospitalized with community-acquired pneumonia
NCT06577558 / Not yet recruitingPhase 2
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy and Safety of SR1375 in Hospitalized Adult Patients With Community-acquired Pneumonia
ChiCTR2300067741 / RecruitingPhase 2IIT
A Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of SR1375 in Hospitalized Patients With Pneumonia
100 Clinical Results associated with SR-1375
Login to view more data
100 Translational Medicine associated with SR-1375
Login to view more data
100 Patents (Medical) associated with SR-1375
Login to view more data
100 Deals associated with SR-1375
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Community Acquired PneumoniaPhase 2-
Shanghai SIMR Biotech Co., Ltd.Shanghai SIMR Biotech Co., Ltd.
28 Aug 2024
NeuroinflammationPhase 2
CN
Shanghai SIMR Biotech Co., Ltd.Shanghai SIMR Biotech Co., Ltd.
18 Nov 2022
Diabetic macular oedemaPhase 1
CN
SIMR (Australia) Biotech Pty Ltd
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free